Cardiovascular outcomes of oral incretin-based drugs in type 2 diabetes: a GRADE-assessed meta-analysis of 67,679 patients.

Ali MF, Mohammed OF, Suhail A, Naseer F, Shafi N, Arshad MU, Shazly O, Mohmand MS, Ahmad H, Binashikhbubkr NK, Maaz M, Khan M, Neppala S, Al-Jarshawi M, Hemida MF

Open source

DOI: 10.3389/fcvm.2026.1884895
Published: 2026
Container: Frontiers in cardiovascular medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2026.1884895,
  title = {Cardiovascular outcomes of oral incretin-based drugs in type 2 diabetes: a GRADE-assessed meta-analysis of 67,679 patients.},
  author = {Ali MF and Mohammed OF and Suhail A and Naseer F and Shafi N and Arshad MU and Shazly O and Mohmand MS and Ahmad H and Binashikhbubkr NK and Maaz M and Khan M and Neppala S and Al-Jarshawi M and Hemida MF},
  year = {2026},
  journal = {Frontiers in cardiovascular medicine},
  doi = {10.3389/fcvm.2026.1884895},
  url = {https://doi.org/10.3389/fcvm.2026.1884895}
}

RIS

TY  - JOUR
TI  - Cardiovascular outcomes of oral incretin-based drugs in type 2 diabetes: a GRADE-assessed meta-analysis of 67,679 patients.
AU  - Ali MF
AU  - Mohammed OF
AU  - Suhail A
AU  - Naseer F
AU  - Shafi N
AU  - Arshad MU
AU  - Shazly O
AU  - Mohmand MS
AU  - Ahmad H
AU  - Binashikhbubkr NK
AU  - Maaz M
AU  - Khan M
AU  - Neppala S
AU  - Al-Jarshawi M
AU  - Hemida MF
PY  - 2026
JO  - Frontiers in cardiovascular medicine
DO  - 10.3389/fcvm.2026.1884895
UR  - https://doi.org/10.3389/fcvm.2026.1884895
ER  -

APA

MF, A., OF, M., A, S., F, N., N, S., MU, A., O, S., MS, M., H, A., NK, B., M, M., M, K., S, N., M, A., & MF, H. (2026). Cardiovascular outcomes of oral incretin-based drugs in type 2 diabetes: a GRADE-assessed meta-analysis of 67,679 patients.. Frontiers in cardiovascular medicine. https://doi.org/10.3389/fcvm.2026.1884895

Source records

pubmed · retrieved 2026-11-10T12:37:10.754Z